EE03806B1 - Lamivudiini ja sidovudiini sisaldavad farmatseutilised kompositsioonid - Google Patents

Lamivudiini ja sidovudiini sisaldavad farmatseutilised kompositsioonid

Info

Publication number
EE03806B1
EE03806B1 EEP199900175A EE9900175A EE03806B1 EE 03806 B1 EE03806 B1 EE 03806B1 EE P199900175 A EEP199900175 A EE P199900175A EE 9900175 A EE9900175 A EE 9900175A EE 03806 B1 EE03806 B1 EE 03806B1
Authority
EE
Estonia
Prior art keywords
zidovudine
pharmaceutical compositions
compositions containing
containing lamivudine
lamivudine
Prior art date
Application number
EEP199900175A
Other languages
English (en)
Other versions
EE9900175A (et
Inventor
Wayne Goodson Gary
Wayne Wood Allen
Jeannette Ford Katherine
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of EE9900175A publication Critical patent/EE9900175A/et
Publication of EE03806B1 publication Critical patent/EE03806B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
EEP199900175A 1996-10-31 1997-10-29 Lamivudiini ja sidovudiini sisaldavad farmatseutilised kompositsioonid EE03806B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9622681.6A GB9622681D0 (en) 1996-10-31 1996-10-31 Pharmaceutical compositions
PCT/EP1997/005953 WO1998018477A2 (en) 1996-10-31 1997-10-29 Pharmaceutical compositions containing lamivudine and zidovudine

Publications (2)

Publication Number Publication Date
EE9900175A EE9900175A (et) 1999-12-15
EE03806B1 true EE03806B1 (et) 2002-08-15

Family

ID=10802224

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900175A EE03806B1 (et) 1996-10-31 1997-10-29 Lamivudiini ja sidovudiini sisaldavad farmatseutilised kompositsioonid

Country Status (44)

Country Link
EP (1) EP0941100B1 (et)
JP (1) JP2001502718A (et)
KR (1) KR100551652B1 (et)
AP (1) AP1067A (et)
AR (1) AR009135A1 (et)
AT (1) ATE241364T1 (et)
AU (1) AU736607B2 (et)
BG (1) BG64541B1 (et)
BR (1) BR9712614A (et)
CA (1) CA2270174A1 (et)
CO (1) CO4930269A1 (et)
CY (1) CY2485B1 (et)
CZ (1) CZ296080B6 (et)
DE (1) DE69722433T2 (et)
DK (1) DK0941100T3 (et)
EA (1) EA002437B1 (et)
EE (1) EE03806B1 (et)
ES (1) ES2200204T3 (et)
GB (1) GB9622681D0 (et)
GE (1) GEP20022735B (et)
GT (1) GT199700116A (et)
HK (1) HK1020880A1 (et)
HR (1) HRP970569B1 (et)
HU (1) HU224969B1 (et)
ID (1) ID18698A (et)
IL (1) IL129422A0 (et)
IS (1) IS5024A (et)
MY (1) MY119513A (et)
NO (1) NO317163B1 (et)
NZ (1) NZ335153A (et)
OA (1) OA11038A (et)
PA (1) PA8441101A1 (et)
PE (1) PE10099A1 (et)
PL (1) PL190349B1 (et)
PT (1) PT941100E (et)
SI (1) SI0941100T1 (et)
SK (1) SK284286B6 (et)
SV (1) SV1997000090A (et)
TR (1) TR199900950T2 (et)
UA (1) UA64725C2 (et)
UY (1) UY24766A1 (et)
WO (1) WO1998018477A2 (et)
YU (1) YU19999A (et)
ZA (1) ZA979726B (et)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9622681D0 (en) * 1996-10-31 1997-01-08 Glaxo Group Ltd Pharmaceutical compositions
GB9809213D0 (en) * 1998-04-29 1998-07-01 Glaxo Group Ltd Pharmaceutical compositions
US7074417B2 (en) * 2000-10-13 2006-07-11 Advancis Pharmaceutical Corporation Multiple-delayed release anti-viral product, use and formulation thereof
CZ20041117A3 (cs) * 2002-04-23 2005-04-13 Lupin Limited Dlouhodobě působící kompozice zahrnující zidovudin a lamivudin
WO2004043433A2 (en) * 2002-11-08 2004-05-27 Glaxo Group Limited Pharmaceutical antiviral compositions
KR20090053867A (ko) 2003-01-14 2009-05-27 길리애드 사이언시즈, 인코포레이티드 복합 항바이러스 치료를 위한 조성물 및 방법
AR045841A1 (es) * 2004-09-28 2005-11-16 Richmond Sa Com Ind Y Financie Una composicion farmaceutica solida que comprende al tiazolil metil ester del acido [5s-(5r*, 8r*, 10r*,11r*)] -10- hidroxi-2- metil-5-(1-metiletil)-1-[2-(1-metiletil)-4-tiazolil]-3,6-dioxo-8,11-bis(fenilmetil)-2,4,7,12- tetraazatridecan-13-oico y un procedimiento para prepararla.
EP2579892A2 (en) 2010-06-09 2013-04-17 Vaccine Technologies, Incorporated Therapeutic immunization in hiv infected subjects receiving stable antiretroviral treatment
US20150104511A1 (en) 2012-03-05 2015-04-16 Cipla Limited Pharmaceutical Antiretroviral Combinations Comprising Lamivudine, Festinavir and Nevirapine
EP2958563A2 (en) * 2013-02-20 2015-12-30 AbbVie Inc. Tablet dosage form comprising ritonavir and lopinavir

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950652A (en) * 1987-03-23 1990-08-21 Hem Research, Inc. dsRNAs for combination therapy in the treatment of viral diseases
GB9110624D0 (en) * 1991-05-16 1991-07-03 Glaxo Group Ltd Combinations
CZ285232B6 (cs) * 1991-05-16 1999-06-16 Glaxo Group Limited Protivirové směsi
GB9622681D0 (en) * 1996-10-31 1997-01-08 Glaxo Group Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
NO992091D0 (no) 1999-04-29
CZ155799A3 (cs) 1999-10-13
HRP970569B1 (en) 2004-10-31
WO1998018477A3 (en) 1998-06-18
AU5314298A (en) 1998-05-22
HUP0000344A2 (hu) 2001-05-28
SK57599A3 (en) 2000-06-12
YU19999A (sh) 2000-10-30
HU224969B1 (en) 2006-04-28
ID18698A (id) 1998-04-30
MY119513A (en) 2005-06-30
ATE241364T1 (de) 2003-06-15
GEP20022735B (en) 2002-07-25
NO992091L (no) 1999-06-29
GB9622681D0 (en) 1997-01-08
ES2200204T3 (es) 2004-03-01
PA8441101A1 (es) 2000-05-24
CO4930269A1 (es) 2000-06-27
SI0941100T1 (en) 2003-12-31
IL129422A0 (en) 2000-02-17
WO1998018477A2 (en) 1998-05-07
SV1997000090A (es) 1998-10-07
UA64725C2 (uk) 2004-03-15
HRP970569A2 (en) 1998-08-31
DK0941100T3 (da) 2003-09-01
KR100551652B1 (ko) 2006-02-13
KR20000052893A (ko) 2000-08-25
JP2001502718A (ja) 2001-02-27
BG103435A (en) 2000-04-28
HUP0000344A3 (en) 2002-04-29
BG64541B1 (bg) 2005-07-29
DE69722433D1 (de) 2003-07-03
PE10099A1 (es) 1999-03-02
ZA979726B (en) 1999-04-29
PL190349B1 (pl) 2005-11-30
AP1067A (en) 2002-05-01
AU736607B2 (en) 2001-08-02
CA2270174A1 (en) 1998-05-07
IS5024A (is) 1999-04-09
BR9712614A (pt) 1999-10-26
HK1020880A1 (en) 2000-05-26
EE9900175A (et) 1999-12-15
CY2485B1 (en) 2005-06-03
EA002437B1 (ru) 2002-04-25
AR009135A1 (es) 2000-03-08
AP9901519A0 (en) 1999-06-30
PT941100E (pt) 2003-10-31
CZ296080B6 (cs) 2006-01-11
DE69722433T2 (de) 2004-04-08
GT199700116A (es) 1999-04-22
PL333143A1 (en) 1999-11-22
EP0941100A2 (en) 1999-09-15
OA11038A (en) 2002-02-06
NZ335153A (en) 2001-04-27
EP0941100B1 (en) 2003-05-28
UY24766A1 (es) 2000-12-29
SK284286B6 (sk) 2005-01-03
NO317163B1 (no) 2004-08-30
EA199900345A1 (ru) 2000-02-28
TR199900950T2 (xx) 1999-07-21

Similar Documents

Publication Publication Date Title
NO20002359L (no) Adenosinderivater og farmasoytisk sammensetning inneholdende derivatene
NO20021172D0 (no) Farmasöytisk sammensetning
CY2005007I1 (el) Φαρμακευτικες συνθεσεις που περιεχουν δαριφενακινη
FI973475A (fi) Koostumus ja sitä sisältävä tuote
EE200000646A (et) Abakaviiri, lamivudiini ja zidovudiini sisaldavadhomogeensed farmatseutilised kompositsioonid
BR9509688A (pt) Composto e composição farmacêutica
EE03806B1 (et) Lamivudiini ja sidovudiini sisaldavad farmatseutilised kompositsioonid
BR9507768A (pt) Composição farmacêutica
ID29294A (id) Komposisi farmasi
FI973229A0 (fi) Uusi farmaseuttinen koostumus
LV11727A (lv) Farmaceitiska kompozicija
ID25857A (id) Komposisi farmasi
FI973280A0 (fi) Farmaseuttinen koostumus
ITMI962628A0 (it) Composizione farmaceutica
BR9605777A (pt) Composição farmacêutica
ID23531A (id) Komposisi farmasi
IT1272935B (it) Composizione farmaceutica contenente n-acetil-cisteina
NO964309D0 (no) Farmasöytisk sammensetning
BR1100391A (pt) Composto e composição farmacêutica
FI955181A0 (fi) Trymoktonaania ja ATZ:ä sisältävät farmaseuttiset koostumuset
BR1100838A (pt) Composto e composição farmacêutica
SE9604299D0 (sv) Pharmaceutical composition
SE9601854D0 (sv) Farmaceutisk komposition
ID17133A (id) Komposisi farmasi
BR1101151A (pt) Compostos e composição farmacêutica

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

MA4A Abandonment or withdrawal

Effective date: 20060815